S

Synthaverse SA
WSE:SVE

Watchlist Manager
Synthaverse SA
WSE:SVE
Watchlist
Price: 4.14 PLN -2.47% Market Closed
Market Cap: 293m PLN
Have any thoughts about
Synthaverse SA?
Write Note

Synthaverse SA
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Synthaverse SA
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
S
Synthaverse SA
WSE:SVE
Deferred Income Tax
zł1.4m
CAGR 3-Years
25%
CAGR 5-Years
14%
CAGR 10-Years
30%
M
Mabion SA
WSE:MAB
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Read Gene SA
WSE:RDG
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genomed SA
WSE:GEN
Deferred Income Tax
zł5.5k
CAGR 3-Years
-35%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
B
Bioton SA
WSE:BIO
Deferred Income Tax
zł3.3m
CAGR 3-Years
N/A
CAGR 5-Years
83%
CAGR 10-Years
-29%
U
Urteste SA
WSE:URT
Deferred Income Tax
zł3k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Synthaverse SA
Glance View

Market Cap
292m PLN
Industry
Biotechnology

Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. The company is headquartered in Lublin, Woj. Lubelskie and currently employs 234 full-time employees. The company went IPO on 2011-07-29. The firm focuses on the production of drugs in the field of immunotherapy. Synthaverse SA offers its services in the field such as: oncological immunotherapy, Immunotherapy in Serological Conflict, Passive immunotherapy in hepatitis B, Active anti-tuberculosis immunotherapy, Gynecology and Proctology, Probiotics, Laboratory reagents. The firm offers injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, suppository forms of drugs. The firm supplies its products to 50 countries around the world.

SVE Intrinsic Value
6.96 PLN
Undervaluation 40%
Intrinsic Value
Price
S

See Also

What is Synthaverse SA's Deferred Income Tax?
Deferred Income Tax
1.4m PLN

Based on the financial report for Jun 30, 2024, Synthaverse SA's Deferred Income Tax amounts to 1.4m PLN.

What is Synthaverse SA's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
30%

Over the last year, the Deferred Income Tax growth was 17%. The average annual Deferred Income Tax growth rates for Synthaverse SA have been 25% over the past three years , 14% over the past five years , and 30% over the past ten years .

Back to Top